CONSUMER PORTFOLIO SERVICES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CONSUMER PORTFOLIO SERVICES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $434.47M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $393.51M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $352.01M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $329.71M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $267.81M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $271.16M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $345.80M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $389.78M | Mar 10, 2021 |
| FY2017 | Dec 31, 2017 | $107.23M | Mar 7, 2018 |
| FY2017 | Sep 30, 2017 | $109.49M | Mar 7, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.33M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $19.20M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $45.34M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $85.98M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $47.52M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $21.68M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $5.41M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $14.86M | Mar 10, 2021 |
| FY2017 | Dec 31, 2017 | ($9.95M) | Mar 7, 2018 |
| FY2017 | Sep 30, 2017 | $4.66M | Mar 7, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $289.00M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $233.76M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $237.98M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $215.93M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $198.19M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $238.77M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $216.78M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $216.21M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $215.65M | Mar 16, 2020 |
| FY2018 | Dec 31, 2016 | $196.33M | Mar 13, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $709.0K | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $433.0K | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $559.0K | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $2.15M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.98M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $24.0K | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $751.0K | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $1.08M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $669.0K | Mar 16, 2020 |
| FY2018 | Dec 31, 2016 | $1.08M | Mar 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.86B | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $3.49B | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $2.90B | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $2.75B | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.16B | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $2.15B | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $2.54B | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $2.49B | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $2.42B | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $2.41B | Mar 7, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.55B | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $3.20B | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $2.63B | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $2.52B | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.99B | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $2.01B | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $2.34B | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $2.29B | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $2.24B | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $2.22B | Mar 7, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $309.54M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $292.77M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $274.67M | Mar 16, 2026 |
| FY2025 | Dec 31, 2022 | $228.39M | Mar 16, 2026 |
| FY2024 | Dec 31, 2021 | $170.21M | Mar 12, 2025 |
| FY2023 | Dec 31, 2020 | $133.36M | Mar 15, 2024 |
| FY2022 | Dec 31, 2019 | $110.17M | Mar 16, 2023 |
| FY2021 | Dec 31, 2018 | $197.12M | Mar 16, 2022 |
| FY2020 | Dec 31, 2017 | $183.94M | Mar 10, 2021 |
| FY2019 | Dec 31, 2016 | $186.22M | Mar 16, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $286.39M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $267.06M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $247.86M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $202.51M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $116.53M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $69.01M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $139.81M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $134.40M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $119.54M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $115.77M | Mar 7, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.32M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $11.71M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $6.17M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $13.49M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $29.93M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $13.47M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $5.30M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $12.79M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $12.73M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $13.94M | Mar 7, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $24.18M | Mar 9, 2016 |
| FY2014 | Dec 31, 2014 | $27.56M | Feb 25, 2015 |
| FY2013 | Dec 31, 2013 | $76.80M | Mar 10, 2014 |
| FY2012 | Dec 31, 2012 | $87.19M | Feb 15, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 10, 2021 |
| FY2017 | Dec 31, 2017 | 0 | Mar 7, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 7, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 10, 2021 |
| FY2017 | Dec 31, 2017 | 0 | Mar 7, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 7, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21.84M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 21.43M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | 21.17M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 20.13M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | 21.14M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 22.74M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | 22.53M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | 22.42M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | 21.49M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | 23.59M | Mar 7, 2018 |